Crinetics Pharmaceuticals, Inc.
CRNX
$37.48
-13.82%
CRNX
Crinetics Pharmaceuticals, Inc.
$37.48
CRNX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crinetics Pharmaceuticals, Inc.'s 12-month outlook, with a consensus price target around $48.72 and implied upside of +30.0% versus the current price.
Average Target
$48.72
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$30 - $49
Analyst target range
CRNX Technical Analysis
Beta
0.28
0.28x market volatility
Max Drawdown
-40.3%
Largest decline past year
52-Week Range
$26-$58
Price range past year
Annual Return
+14.6%
Cumulative gain past year
| Period | CRNX Return | S&P 500 |
|---|---|---|
| 1m | -6.2% | +9.1% |
| 3m | -17.2% | +6.8% |
| 6m | -6.3% | +9.9% |
| 1y | +14.6% | +30.5% |
| ytd | -19.8% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is CRNX Overvalued?
PE
-9.4x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-9.4x
Enterprise Value Multiple
